Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Regional Cerebral Glucose Metabolic Abnormality in Prader–Willi Syndrome: A 18F-FDG PET Study Under Sedation

Sang Eun Kim, Dong-Kyu Jin, Sang Soo Cho, Ji-Hae Kim, Sungdo David Hong, Kyung Hoon Paik, Yoo Joung Oh, An Hee Kim, Eun Kyung Kwon and Yon Ho Choe
Journal of Nuclear Medicine July 2006, 47 (7) 1088-1092;
Sang Eun Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong-Kyu Jin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sang Soo Cho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji-Hae Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sungdo David Hong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyung Hoon Paik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoo Joung Oh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
An Hee Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eun Kyung Kwon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yon Ho Choe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Prader–Willi syndrome (PWS) is a genetic disorder caused by the nonexpression of paternal genes in the PWS region of chromosome 15q11-13 and is the most common cause of human syndromic obesity. Methods: We investigated regional brain metabolic impairment in children with PWS by 18F-FDG PET. Sixteen children with PWS (9 males, 7 females; mean age ± SD, 4.2 ± 1.1 y) and 7 healthy children (4 males, 3 females; mean age ± SD, 4.0 ± 1.7 y) underwent brain 18F-FDG PET in the resting state. The images of PWS children were compared using statistical parametric mapping analysis with those of healthy children in a voxelwise manner. Results: Group comparison showed that children with PWS had decreased glucose metabolism in the right superior temporal gyrus and left cerebellar vermis, regions that are associated with taste perception/food reward and cognitive and emotional function, respectively. Metabolism was increased in the right orbitofrontal, bilateral middle frontal, right inferior frontal, left superior frontal, and bilateral anterior cingulate gyri, right temporal pole, and left uncus, regions that are involved in cognitive functions related to eating or obsessive–compulsive behavior. Interestingly, no significant metabolic abnormality was found in the hypothalamus, the brain region believed to be most involved in energy intake and expenditure. Conclusion: This study describes the neural substrate underlying the abnormal eating behavior and psychobehavioral problems of PWS.

  • Prader–Willi syndrome
  • glucose metabolism
  • PET
  • eating behavior
  • obsessive–compulsive behavior

Prader–Willi syndrome (PWS), the most common cause of syndromic obesity, is caused by the deletion or disruption of a gene or several genes on the proximal long arm of paternal chromosome 15, maternal uniparental disomy, or imprinting defect. These genetic defects occur because the genes on maternal chromosome 15q11-13 are virtually inactive through imprinting (1), which leads to the lack of expression of parental copies of the imprinted SNRPN gene, the necdin gene, and possibly other genes.

Clinically, the syndrome is characterized by various symptoms, including infantile hypotonia and poor sucking reflex, mental retardation, delayed sexual development, and obesity by incessant food intake. Among these symptoms, food-related difficulties are the most striking and widely recognized marker of this syndrome.

In addition to these well-known problems, those with PWS also suffer from a range of psychiatric and behavioral problems—for example, high rates of depression, obsession, and compulsion (2–4). Cognitive deficits such as impaired social cognition, literal mindedness, and cognitive inflexibility are also present in PWS. Neuropsychological studies have demonstrated deficits in attention, working memory, and sequential information processing in PWS patients (5–7), which may be related to frontal lobe dysfunction.

Although morphologic abnormalities in brain imaging are not cardinal features of PWS, several studies have attempted to identify structural problems in the PWS brain (8–10). One study compared anterior pituitary gland sizes, an important site of growth hormone secretion, in PWS and normal control subjects using MRI, but no statistically significant differences were found (8). Another MRI study, which included 5 PWS patients, described subtle morphologic abnormalities, including mild ventriculomegaly, cortical atrophy in the frontal lobe, and a small brain stem (9). Yoshii et al. reported a case of cortical malformation in a 40-wk-old girl with PWS (10). MR images showed a diffusely abnormal gyral folding pattern and multiple regions involving all lobes where the gray–white matter junction was markedly irregular. However, morphologic studies have not provided an insight into the neural substrates underlying the neuropsychiatric, behavioral, and cognitive deficits of PWS.

In an attempt to identify functionally impaired brain regions in PWS and to correlate functional deficits with cognitive and behavioral symptoms, we investigated regional brain metabolic abnormalities in PWS children using 18F-FDG PET.

MATERIALS AND METHODS

Participants

Sixteen children with PWS (9 males, 7 females; mean age ± SD, 4.2 ± 1.1 y) and 7 age- and sex-matched healthy children (4 males, 3 females; mean age ± SD, 4.0 ± 1.7 y) were enrolled in this study.

PWS patients were genetically confirmed using the standard methylation test. Of these 16 patients, 14 had deletion of the paternally transmitted chromosome 15q11-13, whereas the other 2 patients had uniparental disomy. All control subjects were brothers, sisters, or relatives of the patients. They did not have the clinical symptoms of PWS and were negatively confirmed by genetic testing. All control subjects were healthy without a history of seizure disorder. We explained the purpose and methods of this study and obtained informed consent from the parents of the PWS patients and control subjects. The study design was reviewed and approved by the Samsung Medical Center Institutional Review Board. The PWS patients and control subjects had no history of growth hormone or sex hormone treatment and were not being treated with either hormone at study commencement. Clinical characteristics of the PWS patients are summarized in Table 1.

View this table:
  • View inline
  • View popup
TABLE 1

Clinical Characteristics of PWS Patients and Control Subjects

18F-FDG PET Procedures

PET scans of 10 min were acquired in 3-dimensional (3D) mode using an Advance PET scanner (GE Healthcare), starting 40 min after the intravenous injection of 4.8 MBq/kg 18F-FDG. In-plane and axial resolutions of the scanner were 4.9-mm and 3.9-mm full width at half maximum (FWHM), respectively. Subjects were fasted for at least 4 h before PET. Thirty minutes before PET scans, study subjects were orally sedated with chloral hydrate (50 mg/kg). PET images were reconstructed using a Hanning filter (cutoff frequency = 4.5 mm) and displayed in a 128 × 128 matrix (pixel size = 1.95 × 1.95 mm with a slice thickness of 4.25 mm). Attenuation correction was performed with a uniform attenuation coefficient (μ = 0.096 cm−1).

Statistical Parametric Mapping (SPM) Analysis of Regional Glucose Metabolism

Before statistical analysis, using SPM99 (Wellcome Department of Cognitive Neurology, Institute of Neurology, London, U.K.) (11) implanted in the Matlab 5.3 environment (MathWorks Inc.), all images were preprocessed for spatial normalization into the MNI (Montreal Neurologic Institute) template to remove intersubject anatomic variabilities, then smoothed with a FWHM 16-mm gaussian kernel to increase the signal-to-noise ratio and to remove subtle variations in anatomic structures. Individual voxel counts were normalized versus total brain counts (proportional scaling in SPM) to remove individual global brain metabolism differences. After spatial and count normalization, significant differences in glucose metabolism between PWS and healthy children were estimated at every voxel using t statistics. Abnormal glucose metabolism was investigated in brain areas at a height threshold of uncorrected P = 0.001 and at an extent threshold of 70 voxels for between-group analysis and at a height threshold of uncorrected P = 0.01 and an extent threshold of 70 voxels for individual-to-group analyses, after adjusting for the age factor as a covariate of no interest. To visualize the t-score statistics (SPM{t} map), significant voxels were projected onto the 3D rendered brain and a standard high-resolution MRI template provided by SPM99, thus allowing anatomic identification. The MNI coordinates of the local maximum of each cluster were converted into Talairach–Tournoux coordinates (12).

RESULTS

Figure 1 and Table 2 show brain regions with abnormal glucose metabolism in the PWS group versus the control group. Significant hypometabolism was observed in the right superior temporal gyrus and left cerebellar vermis. Metabolism was significantly elevated in the right orbitofrontal, bilateral middle frontal, right inferior frontal, and left superior frontal gyri. In addition, significant hypermetabolism was found in the bilateral anterior cingulate gyri, the right temporal pole, and the left uncus. Interestingly, no significant metabolic abnormality was found in the hypothalamus, the brain region believed to be most involved in energy intake and energy expenditure.

FIGURE 1. 
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1. 

Hypo- and hypermetabolic regions in PWS patients vs. healthy control subjects. These regions are displayed on surface rendered and transaxial images. Brain regions of abnormal glucose metabolism are displayed using height threshold of uncorrected P = 0.001 and extent threshold of 70 voxels, after removing age as a covariate of no interest. Numbers in each transaxial brain image indicate distance (mm) from the anterior commissure–posterior commissure plane.

View this table:
  • View inline
  • View popup
TABLE 2

Hypo- and Hypermetabolic Regions in PWS Patient Group

Results of individual analysis are shown in Table 3, which confirm the group analysis findings. Hypometabolism in the superior temporal gyrus was found in 9 of the 16 patients. Most of the patients had hypermetabolism in the orbitofrontal (12/16), middle frontal (16/16), inferior frontal (6/16), superior frontal (14/16), and anterior cingulate (9/16) gyri and the uncus (10/16).

View this table:
  • View inline
  • View popup
TABLE 3

Hypo- and Hypermetabolic Regions in Individual PWS Patients

DISCUSSION

To our knowledge, the present study is the first functional brain mapping study in children with PWS. Interestingly, the metabolism of several brain areas was found to differ significantly in PWS and age- and sex-matched healthy children. PWS is known to be associated with obesity, but infantile PWS patients are rather weak and poorly nourished. The transition from a poorly nourished to an overweight state usually occurs before 6 y of age. In this study, we included PWS patients at the transitional period to see whether any brain metabolic changes were present at this period.

We attempted to interpret regional metabolic abnormalities versus abnormal eating behavior and psychobehavioral problems in PWS. We found that PWS children have reduced metabolism in the right superior temporal gyrus and left cerebellar vermis, regions that are associated with taste perception/food reward and cognitive and emotional function, respectively. The superior temporal region has been associated with liquid meal taste perception in the unpleasant state of extreme hunger (13). In addition, the superior temporal sulcus and the temporal pole have reciprocal connections with the insula (14), which, as a limbic/paralimbic area, constitutes a part of the taste pathway with the thalamus and hypothalamus, and which is involved in monitoring negative sensory input (15). It has also been suggested that the insular cortex is involved in incentive learning for food rewards (16). Moreover, cognitive and emotional problems may accompany cerebellar abnormalities or be their principal clinical presentation. Pathology in the cerebellar vermis (limbic cerebellum) and lateral hemisphere of the posterior cerebellum (involved in cognitive processing) is associated with cerebellar cognitive affective syndrome, which includes impairments in executive, visual-spatial, and linguistic abilities, with affective disturbances ranging from emotional blunting and depression to disinhibition and psychotic features (17).

In the present study, significant hypermetabolism was found in the right orbitofrontal, bilateral middle frontal, right inferior frontal, left superior frontal, and bilateral anterior cingulate gyri, right temporal pole, and left uncus in PWS children. The pre- and middle frontal and anterior cingulate regions are related to food intake in humans, and the frontal lobe is involved in cognitive functions related to eating; moreover, a feeding-suppression mechanism has been suggested to be located in the frontal lobe (18). Supporting this, frontal regions have been postulated to exert suppressing effects on other cerebral regions, such as the hypothalamus, which respond to food-related stimuli (19). The orbitofrontal cortex is a main cerebral area related to motivation and reward and is especially sensitive to food and monetary reward (20). Studies in nonhuman primates have shown that the orbitofrontal cortex is a cerebral region where responses to visual representations of food are modulated by an animal's hunger status (21). In humans, there was increased activation to visual food stimuli in the medial frontal/orbitofrontal cortex, amygdala, and insula in the premeal condition, which resolved after ingestion of a small meal (22,23). Frontal regions have also been shown to be associated with hunger and satiation in healthy humans—that is, hunger with increased blood flow in the posterior orbitofrontal cortex and satiety with increased blood flow in the ventromedial and dorsolateral prefrontal cortices (24). In obsessive–compulsive disorder, PET studies have identified hypermetabolism in the orbitofrontal cortex, caudate nucleus, and anterior cingulate cortex (25–27). In addition, a volumetric study found that patients with obsessive–compulsive disorder have more total gray matter in the anterior cingulate gyrus (28) Orbitofrontal and anterior cingulate hypermetabolism, which is the most consistent finding in obsessive–compulsive disorder, and which was observed in our PWS patients, may constitute a neural correlate of obsessive–compulsive symptoms in PWS (29–31). Studies in monkeys have revealed a role for the temporal pole in a variety of functions, including taste and olfaction. The uncus is a bulbar allocortical protrusion located in the anterior–inferior medial part of the temporal lobe and receives a projection from the lateral striae of the olfactory tract. Gustatory and olfactory hallucination or auras have long been thought to originate from lesions in this area (32,33). In summary, our results indicate that PWS children have decreased glucose metabolism in the right superior temporal gyrus and left cerebellar vermis, which are associated with taste perception/food reward or cognitive and emotional function, respectively, and increased metabolism in the right orbitofrontal, bilateral middle frontal, right inferior frontal, left superior frontal, and bilateral anterior cingulate gyri, right temporal pole, and left uncus, regions involved in cognitive functions related to eating or obsessive–compulsive behavior.

Recent functional brain imaging studies demonstrated abnormal brain responses after food intake in adults with PWS (34). This study found that the satiety response in the orbitofrontal cortex is insensitive to food intake in PWS adults. Shapira et al. reported a delay in activation after glucose administration in the hypothalamus and other brain regions associated with satiety, such as insula, ventromedial prefrontal cortex, and nucleus accumbens in adults with PWS (35). Interestingly, we found no significant metabolic abnormality in the hypothalamus, which has a major role in the control of food intake. However, neurotracing studies have shown that the hypothalamus receives input from several other regions of the brain (e.g., the amygdala, hippocampal complex, insula, and several polymodal association areas of the prefrontal cortex) that are likely to modulate its activity (36,37). Therefore, the hypothalamus is likely to be only one of several brain centers involved in the regulation of eating behavior, all of which integrate central and peripheral signals before, in turn, transmitting impulses to sets of as yet-unidentified efferent sites. In this context, metabolic abnormalities in the prefrontal and limbic/paralimbic areas, as revealed in the present study, may represent a neural correlate of abnormal food intake in PWS.

This study has some limitations. First, a major limitation of this study is that study subjects were sedated with chloral hydrate before PET. Sedatives are known to lower cerebral glucose metabolism. Although the exact effects of chloral hydrate on cerebral glucose metabolism of pediatric patients are not known, animal studies have reported a 180% elevation of cortical extracellular glucose levels (38) and suppression of the phosphorylation process by hexokinase (39) during chloral hydrate anesthesia. During a state of generalized suppressed 18F-FDG uptake, the differences between children with PWS and children without PWS while awake are likely underestimated. Furthermore, there are differential patterns of suppression of 18F-FDG uptake in different cortical and subcortical structures induced by sedatives or during sleep. Although we found distinct cerebral metabolic features in PWS patients at a similar level of sedation with control subjects during the PET procedure, the extrapolation from the sedated state to the awake state indeed needs to be further proven. Second, the ages of PWS children in our investigation overlap the period from failure to thrive to compulsive overeating. Therefore, further analysis should be done to look at potential differences in brain metabolism during these stages of disease progression. Third, for SPM analysis, we spatially normalized PET images of child brains into the MNI template that is based on adult brains. It might be better to spatially normalize the images into the group template or an age-matched template to obtain more precise statistical results. However, our SPM analysis using an adult template yielded consistent metabolic findings across the patients. Suspicious artifacts, which were observed on the edge or outside the brain profile, could be easily differentiated by visual inspection. In addition, using a standard template (e.g., MNI template) allows more direct comparisons between data from different populations or conditions.

CONCLUSION

Our voxelwise analysis of 18F-FDG PET images of PWS children revealed metabolic abnormalities in brain regions that are directly or indirectly related with food intake and obsessive–compulsive behavior. Thus, this study describes, in part, the neural substrate underlying abnormal eating behavior and psychobehavioral problems (such as obsessions and compulsions) in PWS.

Acknowledgments

This research was supported by the Molecular and Cellular Biodiscovery Research Program (grant M10401000004-05N0100-00410), the IN-SUNG Foundation for Medical Research, and the Real Time Molecular Imaging Technology Development Program (grant M10420000007-05N2000-00710) funded by the Ministry of Science and Technology, Republic of Korea.

Footnotes

  • COPYRIGHT © 2006 by the Society of Nuclear Medicine, Inc.

References

  1. 1.↵
    Mitchell J, Schinzel A, Langlois S, et al. Comparison of phenotype in uniparental disomy and deletion Prader-Willi syndrome: sex specific differences. Am J Med Genet. 1996;65:133–136.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Dimitropoulos A, Feurer ID, Roof E, et al. Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome. Ment Retard Dev Disabil Res Rev. 2000;6:125–130.
    OpenUrlCrossRefPubMed
  3. 3.
    State MW, Dykens EM. Genetics of childhood disorders. XV. Prader-Willi syndrome: genes, brain, and behavior. J Am Acad Child Adolesc Psychiatry. 2000;39:797–800.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Steinhausen HC, Eiholzer U, Hauffa BP, Malin Z. Behavioural and emotional disturbances in people with Prader-Willi syndrome. J Intellect Disabil Res. 2004;48:47–52.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Gross-Tsur V, Landau YE, Benarroch F, Wertman-Elad R, Shalev RS. Cognition, attention, and behavior in Prader-Willi syndrome. J Child Neurol. 2001;16:288–290.
    OpenUrlAbstract/FREE Full Text
  6. 6.
    Pulsifer MB. The neuropsychology of mental retardation. J Int Neuropsychol Soc. 1996;2:159–176.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Stauder JE, Brinkman MJ, Curfs LM. Multi-modal P3 deflation of event-related brain activity in Prader-Willi syndrome. Neurosci Lett. 2002;327:99–102.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Miller L, Angulo M, Price D, Taneja S. MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings. Pediatr Radiol. 1996;26:43–47.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Hashimoto T, Mori K, Yoneda Y, et al. Proton magnetic resonance spectroscopy of the brain in patients with Prader-Willi syndrome. Pediatr Neurol. 1998;18:30–35.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Yoshii A, Krishnamoorthy KS, Grant PE. Abnormal cortical development shown by 3D MRI in Prader-Willi syndrome. Neurology. 2002;59:644–645.
    OpenUrlFREE Full Text
  11. 11.↵
    Friston KJ, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp. 1995;3:165–189.
  12. 12.↵
    Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System—An Approach to Cerebral Imaging. Stuttgart, Germany: Thieme Medical; 1988.
  13. 13.↵
    Gautier JF, Chen K, Uecker A, et al. Regions of the human brain affected during a liquid-meal taste perception in the fasting state: a positron emission tomography study. Am J Clin Nutr. 1999;70:806–810.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev. 1996;22:229–244.
    OpenUrlCrossRefPubMed
  15. 15.↵
    Reiman EM. The application of positron emission tomography to the study of normal and pathologic emotions. J Clin Psychiatry. 1997;58(suppl 16):4–12.
  16. 16.↵
    Balleine BW, Dickinson A. Goal-directed instrumental action: contingency and incentive learning and their cortical substrates. Neuropharmacology. 1998;37:407–419.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 2004;16:367–378.
    OpenUrlCrossRefPubMed
  18. 18.↵
    Nozoe S, Naruo T, Yonekura R, et al. Comparison of regional cerebral blood flow in patients with eating disorders. Brain Res Bull. 1995;36:251–255.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Rolls ET. Neural processing related to feeding in primates. In: Legg CR, Booth D, eds. Appetite: Neural and Behavioural Bases. Oxford, U.K.: Oxford University Press; 1994:11–53.
  20. 20.↵
    Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev. 2002;26:321–352.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Critchley HD, Rolls ET. Hunger and satiety modify the responses of olfactory and visual neurons in the primate orbitofrontal cortex. J Neurophysiol. 1996;75:1673–1686.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    LaBar KS, Gitelman DR, Parrish TB, Kim YH, Nobre AC, Mesulam MM. Hunger selectively modulates corticolimbic activation to food stimuli in humans. Behav Neurosci. 2001;115:493–500.
    OpenUrlCrossRefPubMed
  23. 23.↵
    Holsen LM, Zarcone JR, Thompson TI, et al. Neural mechanisms underlying food motivation in children and adolescents. Neuroimage. 2005;27:669–676.
    OpenUrlCrossRefPubMed
  24. 24.↵
    Tataranni PA, Gautier JF, Chen K, et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci U S A. 1999;96:4569–4574.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44:211–218.
    OpenUrlCrossRefPubMed
  26. 26.
    Kwon JS, Kim JJ, Lee DW, et al. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res. 2003;122:37–47.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Micallef J, Blin O. Neurobiology and clinical pharmacology of obsessive-compulsive disorder. Clin Neuropharmacol. 2001;24:191–207.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Szeszko PR, MacMillan S, McMeniman M, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry. 2004;161:1049–1056.
    OpenUrlCrossRefPubMed
  29. 29.↵
    Clarke DJ, Boer H, Whittington J, Holland A, Butler J, Webb T. Prader-Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry. 2002;180:358–362.
    OpenUrlAbstract/FREE Full Text
  30. 30.
    Dykens EM, Leckman JF, Cassidy SB. Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry. 1996;37:995–1002.
    OpenUrlPubMed
  31. 31.↵
    Feurer ID, Dimitropoulos A, Stone WL, Roof E, Butler MG, Thompson T. The latent variable structure of the Compulsive Behaviour Checklist in people with Prader-Willi syndrome. J Intellect Disabil Res. 1998;42:472–480.
  32. 32.↵
    Geyer JD, Payne TA, Faught E, Drury I. Postictal nose-rubbing in the diagnosis, lateralization, and localization of seizures. Neurology. 1999;52:743–745.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Niedermeyer E, Lopes da Silva FH. Electroencephalography: Basic Principles, Clinical Applications and Related Fields. 2nd ed. Baltimore, MD: Urban & Schwartzenberg; 1987.
  34. 34.↵
    Hinton EC, Holland AJ, Gellatly MS, et al. Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes (Lond). 2006;30:313–321.
    OpenUrlCrossRefPubMed
  35. 35.↵
    Shapira NA, Lessig MC, He AG, James GA, Driscoll DJ, Liu Y. Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI. J Neurol Neurosurg Psychiatry. 2005;76:260–262.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    Berthoud HR. An overview of neural pathways and networks involved in the control of food intake and selection. In: Berthoud HR, Seeley RJ, eds. Neural and Metabolic Control of Macronutrient Intake. Washington, DC: CRC Press; 1999:361–387.
  37. 37.↵
    DeFalco J, Tomishima M, Liu H, et al. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science. 2001;291:2608–2613.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    Netchiporouk L, Shram N, Salvert D, Cespuglio R. Brain extracellular glucose assessed by voltammetry throughout the rat sleep-wake cycle. Eur J Neurosci. 2001;13:1429–1434.
    OpenUrlCrossRefPubMed
  39. 39.↵
    Hosoi R, Matsumura A, Mizokawa S, et al. MicroPET detection of enhanced 18F-FDG utilization by PKA inhibitor in awake rat brain. Brain Res. 2005;1039:199–202.
    OpenUrlCrossRefPubMed
  • Received for publication September 22, 2005.
  • Accepted for publication March 16, 2006.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (7)
Journal of Nuclear Medicine
Vol. 47, Issue 7
July 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Regional Cerebral Glucose Metabolic Abnormality in Prader–Willi Syndrome: A 18F-FDG PET Study Under Sedation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Regional Cerebral Glucose Metabolic Abnormality in Prader–Willi Syndrome: A 18F-FDG PET Study Under Sedation
Sang Eun Kim, Dong-Kyu Jin, Sang Soo Cho, Ji-Hae Kim, Sungdo David Hong, Kyung Hoon Paik, Yoo Joung Oh, An Hee Kim, Eun Kyung Kwon, Yon Ho Choe
Journal of Nuclear Medicine Jul 2006, 47 (7) 1088-1092;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Regional Cerebral Glucose Metabolic Abnormality in Prader–Willi Syndrome: A 18F-FDG PET Study Under Sedation
Sang Eun Kim, Dong-Kyu Jin, Sang Soo Cho, Ji-Hae Kim, Sungdo David Hong, Kyung Hoon Paik, Yoo Joung Oh, An Hee Kim, Eun Kyung Kwon, Yon Ho Choe
Journal of Nuclear Medicine Jul 2006, 47 (7) 1088-1092;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Anomalous basal ganglia connectivity and obsessive-compulsive behaviour in patients with Prader Willi syndrome
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire